Ht1 - Consequences and Validity of an Empirical Estimation of the Nice Cost Effectiveness Threshold

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

External Validity of RCT Evidence in Cost-Effectiveness Analyses. A Review of Recent Technology Appraisals for Nice and Proposed Methods of Adjustment

Trials
MedicinePharmacology
2015English

Future Costs in Cost-Effectiveness Analysis: An Empirical Assessment

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2010English

RS2 Cost-Effectiveness of End-Of-Life, Life-Extending Interventions: NICE's Cost-Effectiveness Threshold Explored

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Prm51 - A New Conceptual Model of the Cost-Effectiveness Threshold

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php232 - A Comparison of Cost-Effectiveness Assessments Between Nice and SMC Technology Appraisals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Draft National Health Policy of India and Determining Cost-Effectiveness Threshold

Journal of Basic and Clinical Pharmacy
2017English

Cv3 - Cost-Effectiveness of Sacubitril/Valsartan in Germany: Applying the Efficiency Threshold

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis

American Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2018English

Prm35 - Incremental Cost Effectiveness Ratio (Icer) Threshold, the End of Horizontal Equity?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy